Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-analysis.

HeeEun KangJohn P UyCaroline C HoHeather B BluntNatalie B RibletAlessandro C PasqualottoRichard A Murphy

Published in: Open forum infectious diseases (2023)

Single, high-dose LAmB is associated with a lower risk of life-threatening AEs compared with other World Health Organization-endorsed amphotericin B-based regimens in invasive HIV-related fungal infection.

Keyphrases

high dose
antiretroviral therapy
hiv positive
hiv infected
hiv testing
human immunodeficiency virus
low dose
stem cell transplantation
hepatitis c virus
hiv aids
men who have sex with men
south africa
cerebrospinal fluid
combination therapy
replacement therapy